Sunovion Pharmaceuticals Inc. Watch

from 8-K 4 pages First Supplemental Indenture

from 8-K 4 pages First Supplemental Indenture

from 10-K 15 pages Unless This Certificate Is Presented by an Authorized Representative of the Depository Trust Company, a New York Corporation ("Dtc"), to the Company or Its Agent for Registration of Transfer, Exchange, or Payment, and Any Certificate Issued Is Registered in the Name of Cede & Co. or in Such Other Name as Is Requested by an Authorized Representative of Dtc (And Any Payment Is Made to Cede & Co. or to Such Other Entity as Is Requested by an Authorized Representative of Dtc), Any Transfer, Pledge, or Other Use Hereof for Value or Otherwise by or to Any Person Is Wrongful Inasmuch as the Registered Owner Hereof, Cede & Co., Has an Interest Herein

from S-3 13 pages Form of Global 0% Convertible Senior Subordinated Note Due 2024 [Face of Global Note]

from 8-K 126 pages Sepracor Inc. as Issuer and Jpmorgan Chase Bank as Trustee Indenture Dated as of September 22, 2004 0% Convertible Senior Subordinated Notes Due 2024

from 10-K ~10 pages Indenture or similar

from 10-K ~10 pages Indenture or similar

from 8-K 113 pages Sepracor Inc. as Issuer and Jpmorgan Chase Bank as Trustee Indenture Dated as of December 12, 2003 0% Series a Convertible Senior Subordinated Notes Due 2008 0% Series B Convertible Senior Subordinated Notes Due 2010

from 8-K ~50 pages Indenture or similar

from S-3 ~10 pages Indenture or similar

from 10-K ~10 pages Indenture or similar

from 10-K ~10 pages Rule 144a Global Debenture

from S-8 ~50 pages Restated Cert. of Incorporation of Sepracor Inc.

from 10-K ~10 pages Global 6 1/4% Convertible Sub. Debenture 2005

from 10-K ~10 pages Form of Convertible Sub. Debenture 2005

from S-8 ~50 pages Restated Certificate of Incorporation

from S-8 ~50 pages Restated Certificate of Incorporation

from S-8 ~50 pages Restated Certificate of Incorporation